Sammanfattning
Postnatal prophylaxis with anti-RhD immunoglobulin has reduced the immunisation rate for RhD-negative women with
an RhD-positive foetus by 80 %. Haemolytic disease of the foetus and newborn has become a rare cause of death. However,
some foetuses do still develop severe anaemia as a result of RhD immunisation and require transfusion. RhD typing of the
foetus via blood samples from RhD-negative mothers and antenatal prophylaxis for women with an RhD-positive foetus will
enable RhD immunisation to be reduced further.